Avalo Therapeutics, Inc. financial data

Symbol
AVTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
540 Gaither Road, Suite 400, Rockville, MD
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Cerecor Inc. (to 8/18/2021)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 70.7 % -2.98%
Quick Ratio 0.07 % -49%
Debt-to-equity -349 % +41.6%
Return On Equity 139 % -63.2%
Return On Assets -51.3 % +32.5%
Operating Margin -6.67K % -5365%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.03M shares -94.9%
Common Stock, Shares, Outstanding 1.03M shares -92.6%
Entity Public Float 4.8M USD -85.2%
Common Stock, Value, Issued 1K USD -92.9%
Weighted Average Number of Shares Outstanding, Basic 1.03M shares +1676%
Weighted Average Number of Shares Outstanding, Diluted 7.65M shares +13046%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 806K USD -95.2%
Selling and Marketing Expense 6.29M USD +180%
General and Administrative Expense 4.53M USD +86.6%
Costs and Expenses 54.6M USD +44.9%
Operating Income (Loss) -53.8M USD -160%
Nonoperating Income (Expense) 17.5M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -36.2M USD -46.4%
Income Tax Expense (Benefit) 13K USD -55.2%
Net Income (Loss) Attributable to Parent -36.2M USD -46.2%
Earnings Per Share, Basic 93.9 USD/shares
Earnings Per Share, Diluted 75.7 USD/shares +90%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 93.4M USD +1381%
Accounts Receivable, after Allowance for Credit Loss, Current 38K USD
Inventory, Net 0 USD -100%
Assets, Current 95.9M USD +1175%
Operating Lease, Right-of-Use Asset 1.21M USD -16.9%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 10.5M USD -27.1%
Assets 108M USD +347%
Accounts Payable, Current 654K USD -12.9%
Employee-related Liabilities, Current 2.41M USD +358%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 96.4M USD +329%
Deferred Income Tax Liabilities, Net 168K USD +7.69%
Operating Lease, Liability, Noncurrent 1.18M USD -23.4%
Other Liabilities, Noncurrent 1.18M USD -23.4%
Liabilities 110M USD +254%
Retained Earnings (Accumulated Deficit) -358M USD -11.3%
Stockholders' Equity Attributable to Parent -13.6M USD -95.3%
Liabilities and Equity 108M USD +347%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.2M USD +38.3%
Net Cash Provided by (Used in) Financing Activities 109M USD +690%
Net Cash Provided by (Used in) Investing Activities 356K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 1.03M shares -92.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 103M USD +2784%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 93.6M USD +1350%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 56.9M USD +8.71%
Deferred Tax Assets, Gross 56.8M USD +8.71%
Operating Lease, Liability 1.73M USD -16.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -121M USD -1118%
Lessee, Operating Lease, Liability, to be Paid 2.07M USD -20.1%
Operating Lease, Liability, Current 548K USD +2.43%
Lessee, Operating Lease, Liability, to be Paid, Year Two 563K USD +2.93%
Lessee, Operating Lease, Liability, to be Paid, Year One 553K USD +2.98%
Deferred Income Tax Expense (Benefit) 7K USD -12.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 340K USD -33.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 259K USD -53.5%
Deferred Tax Assets, Operating Loss Carryforwards 37.3M USD +15.1%
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 201K USD -22.1%
Additional Paid in Capital 344M USD +9.4%
Amortization of Intangible Assets 0 USD -100%
Depreciation, Depletion and Amortization 34K USD +3.03%
Share-based Payment Arrangement, Expense 2.83M USD -14.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%